Pseudoexon (6 Ψ) mutation in three siblings with growth hormone insensitivity: response to rIGF-I therapy

被引：0
|
作者：
Diaz, Marta [1 ]
Hwa, Vivian [2 ]
Sebastiani, Giorgia [1 ]
Derr, Michael [2 ]
Valls, Carme [1 ]
Lopez-Bermejo, Abel [3 ]
Rosenfeld, Ron G. [2 ]
Ibanez, Lourdes [1 ]
机构：
[1] Univ Barcelona, Hosp St Joan de Deu, Barcelona, Spain
[2] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA
[3] Univ Girona, Hosp Dr Josep Trueta, Girona, Spain
来源：
HORMONE RESEARCH | 2009年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [21] Long-term therapy with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome (GHIS)
    Backeljauw, PF
    Underwood, LE
    PEDIATRIC RESEARCH, 2000, 47 (04) : 124A - 124A
  • [22] Hearing loss in patients with Laron syndrome (primary growth hormone insensitivity) is reversed by early IGF-I replacement therapy
    Attias, Joseph
    Negeris, Benny
    Zarhi, Omer
    Laron, Zvi
    HORMONE RESEARCH, 2008, 70 : 84 - 84
  • [23] Improved growth and bone mineral density in type I trichorhinophalangeal syndrome in response to growth hormone therapy
    Sarafoglou, K.
    Moassesfar, S.
    Miller, B. S.
    CLINICAL GENETICS, 2010, 78 (06) : 591 - 593
  • [24] Growth response to rhIGF-I 80 μg/kg twice daily in children with growth hormone insensitivity syndrome:: relationship to severity of clinical phenotype
    Azcona, C
    Preece, MA
    Rose, SJ
    Fraser, N
    Rappaport, R
    Ranke, MB
    Savage, MO
    CLINICAL ENDOCRINOLOGY, 1999, 51 (06) : 787 - 792
  • [25] A patient with a novel homozygous mutation in IGF1-R gene and response to growth hormone therapy
    Nasser, Al Shidhani Azza
    Al-Kindi, Adila
    Ullah, Irfan
    Al Saffar, Hussein
    Al Yaarubi, Saif
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 237 - 237
  • [26] Effects of insulin-like growth factor-I deficiency and replacement therapy on the hematopoietic system in patients with Laron syndrome (Primary growth hormone insensitivity)
    Sivan, B
    Lilos, P
    Laron, Z
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2003, 16 (04): : 509 - 520
  • [27] Response to Growth Hormone Therapy in Children with Noonan Syndrome: Correlation with or without PTPN11 Gene Mutation
    Choi, Jin-Ho
    Lee, Beom Hee
    Jung, Chang-Woo
    Kim, Yoo-Mi
    Jin, Hye Young
    Kim, Jae-Min
    Kim, Gu-Hwan
    Hwang, Jin Soon
    Yang, Sei Won
    Lee, Jin
    Yoo, Han-Wook
    HORMONE RESEARCH IN PAEDIATRICS, 2012, 77 (06): : 388 - 393
  • [28] Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: A clinical research center study
    Backeljauw, PF
    Underwood, LE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04): : 1504 - 1510
  • [29] Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models
    Smyczynska, Urszula
    Smyczynska, Joanna
    Hilczer, Maciej
    Stawerska, Renata
    Tadeusiewicz, Ryszard
    Lewinski, Andrzej
    ENDOCRINE CONNECTIONS, 2018, 7 (01): : 239 - 249
  • [30] Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor
    Meyer, S.
    Ipek, M.
    Keth, A.
    Minnemann, T.
    von Mach, M. A.
    Weise, A.
    Ittner, J. R.
    Nawroth, P. P.
    Ploeckinger, U.
    Stalla, G. K.
    Tuschy, U.
    Weber, M. M.
    Kann, P. H.
    GROWTH HORMONE & IGF RESEARCH, 2007, 17 (04) : 307 - 314
12345